The role of amyloid oligomers in neurodegenerative pathologies DOI Creative Commons
Cameron I. Wells,

Samuel Brennan,

Matt Keon

и другие.

International Journal of Biological Macromolecules, Год журнала: 2021, Номер 181, С. 582 - 604

Опубликована: Март 23, 2021

Many neurodegenerative diseases are rooted in the activities of amyloid-like proteins which possess conformations that spread to healthy proteins. These include Alzheimer's disease (AD), Parkinson's (PD), Huntington's (HD) and amyotrophic lateral sclerosis (ALS). While their clinical manifestations vary, protein-level mechanisms remarkably similar. Aberrant monomeric undergo conformational shifts, facilitating aggregation formation solid fibrils. However, there is growing evidence intermediate oligomeric stages key drivers neuronal toxicity. Analysis protein dynamics complicated by fact nucleation growth not a linear pathway. Feedback within this pathway results exponential acceleration aggregation, but exerted oligomers fibrils can alter cellular interactions environment as whole. The resulting cascade effects likely contributes late onset accelerating progression disorders widespread they have on body. In review we explore associated with AD, PD, HD ALS, well common aggregation. From this, identify core elements pathological been targeted for therapies, may become future therapeutic targets.

Язык: Английский

Biomarkers for neurodegenerative diseases DOI
Oskar Hansson

Nature Medicine, Год журнала: 2021, Номер 27(6), С. 954 - 963

Опубликована: Июнь 1, 2021

Язык: Английский

Процитировано

741

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer’s Disease, Parkinson’s Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis DOI
Phuong H. Nguyen, Ayyalusamy Ramamoorthy, Bikash R. Sahoo

и другие.

Chemical Reviews, Год журнала: 2021, Номер 121(4), С. 2545 - 2647

Опубликована: Фев. 5, 2021

Protein misfolding and aggregation is observed in many amyloidogenic diseases affecting either the central nervous system or a variety of peripheral tissues. Structural dynamic characterization all species along pathways from monomers to fibrils challenging by experimental computational means because they involve intrinsically disordered proteins most diseases. Yet understanding how amyloid become toxic challenge developing treatment for these Here we review what computer, vitro, vivo, pharmacological experiments tell us about accumulation deposition oligomers (Aβ, tau), α-synuclein, IAPP, superoxide dismutase 1 proteins, which have been mainstream concept underlying Alzheimer's disease (AD), Parkinson's (PD), type II diabetes (T2D), amyotrophic lateral sclerosis (ALS) research, respectively, years.

Язык: Английский

Процитировано

539

Dynamics of oligomer populations formed during the aggregation of Alzheimer’s Aβ42 peptide DOI
Thomas C. T. Michaels, Anđela Šarić, Samo Curk

и другие.

Nature Chemistry, Год журнала: 2020, Номер 12(5), С. 445 - 451

Опубликована: Апрель 13, 2020

Язык: Английский

Процитировано

291

Amyloid structures: much more than just a cross-β fold DOI Creative Commons
Rodrigo Gallardo, Neil A. Ranson, Sheena E. Radford

и другие.

Current Opinion in Structural Biology, Год журнала: 2019, Номер 60, С. 7 - 16

Опубликована: Ноя. 3, 2019

In recent years our understanding of amyloid structure has been revolutionised by innovations in cryo-electron microscopy, electron diffraction and solid-state NMR. These techniques have yielded high-resolution structures fibrils isolated from patients with neurodegenerative disease, as well those formed amyloidogenic proteins vitro. The results not only show the expected cross-β structure, but also reveal that fold is unexpectedly diverse complex. Here, we discuss this diversity, highlighting dynamic regions, ligand binding motifs, cavities, non-protein components, structural polymorphism. Collectively, these variations combine to allow generic be realised three dimensions different ways, diversity may related roles disease.

Язык: Английский

Процитировано

180

Structure and Aggregation Mechanisms in Amyloids DOI Creative Commons
Zaida L. Almeida, Rui M. M. Brito

Molecules, Год журнала: 2020, Номер 25(5), С. 1195 - 1195

Опубликована: Март 6, 2020

The aggregation of a polypeptide chain into amyloid fibrils and their accumulation deposition insoluble plaques intracellular inclusions is the hallmark several misfolding diseases known as amyloidoses. Alzheimer's, Parkinson's Huntington's are some approximately 50 described to date. identification characterization molecular species critical for formation disease development have been focus intense scrutiny. Methods such X-ray electron diffraction, solid-state nuclear magnetic resonance spectroscopy (ssNMR) cryo-electron microscopy (cryo-EM) extensively used they contributed shed new light onto structure amyloid, revealing multiplicity polymorphic structures that generally fit cross-β motif. rational therapeutic approaches against these debilitating increasingly frequent requires thorough understanding mechanisms underlying cascade. Here, we review current knowledge on fibril proteins peptides from kinetic thermodynamic point view, involved in amyloidogenic process, origin cytotoxicity.

Язык: Английский

Процитировано

175

Simulation Studies of Amyloidogenic Polypeptides and Their Aggregates DOI
Ioana M. Ilie, Amedeo Caflisch

Chemical Reviews, Год журнала: 2019, Номер 119(12), С. 6956 - 6993

Опубликована: Апрель 11, 2019

Amyloids, fibrillar assembly of (poly)peptide chains, are associated with neurodegenerative illnesses such as Alzheimer's and Parkinson's diseases, for which there no cures. The molecular mechanisms the formation toxic species still elusive. Some peptides proteins can form functional amyloid-like aggregates mainly in bacteria fungi but also humans. Little is known on differences self-assembly pathogenic (poly)peptides. We review atomistic coarse-grained simulation studies amyloid their monomeric, oligomeric, states. Particular emphasis given to challenges one faces characterize at atomic level detail conformational space disordered (poly)peptides aggregation. discuss difficulties comparing results experimental data, we propose new shed light aggregation processes diseases.

Язык: Английский

Процитировано

170

Extracellular protein components of amyloid plaques and their roles in Alzheimer’s disease pathology DOI Creative Commons
M. Mahafuzur Rahman, Christofer Lendel

Molecular Neurodegeneration, Год журнала: 2021, Номер 16(1)

Опубликована: Авг. 28, 2021

Abstract Alzheimer’s disease (AD) is pathologically defined by the presence of fibrillar amyloid β (Aβ) peptide in extracellular senile plaques and tau filaments intracellular neurofibrillary tangles. Extensive research has focused on understanding assembly mechanisms neurotoxic effects Aβ during last decades but still we only have a brief associated biological processes. This review highlights many other constituents that, beside Aβ, are accumulated plaques, with focus proteins. All living organisms rely delicate network protein functionality. Deposition significant amounts certain proteins insoluble inclusions will unquestionably lead to disturbances network, which may contribute AD copathology. paper provide comprehensive overview that been shown interact discussion their potential roles pathology. Methods can expand knowledge about how incorporated described. Top-down methods analyze post-mortem tissue bottom-up approaches molecular insights organization plaque-like particles compared. Finally, analysis Aβ-interacting partners enriched functional structural key words presented.

Язык: Английский

Процитировано

153

The Amyloid Phenomenon and Its Significance in Biology and Medicine DOI Open Access
Christopher M. Dobson, Tuomas P. J. Knowles, Michele Vendruscolo

и другие.

Cold Spring Harbor Perspectives in Biology, Год журнала: 2019, Номер 12(2), С. a033878 - a033878

Опубликована: Апрель 1, 2019

Christopher M. Dobson, Tuomas P.J. Knowles and Michele Vendruscolo Centre for Misfolding Diseases, Department of Chemistry, University Cambridge, Cambridge CB2 1EW, United Kingdom Correspondence: cmd44{at}cam.ac.uk; tpjk2{at}cam.ac.uk; mv245{at}cam.ac.uk

Язык: Английский

Процитировано

152

Condensates formed by prion-like low-complexity domains have small-world network structures and interfaces defined by expanded conformations DOI Creative Commons
Mina Farag, Samuel R. Cohen, Wade M. Borcherds

и другие.

Nature Communications, Год журнала: 2022, Номер 13(1)

Опубликована: Дек. 13, 2022

Abstract Biomolecular condensates form via coupled associative and segregative phase transitions of multivalent macromolecules. Phase separation to percolation is one example such transitions. Here, we characterize molecular mesoscale structural descriptions formed by intrinsically disordered prion-like low complexity domains (PLCDs). These systems conform sticker-and-spacers architectures. Stickers are cohesive motifs that drive interactions through reversible crosslinking spacers affect the cooperativity overall macromolecular solubility. Our computations reproduce experimentally measured sequence-specific behaviors PLCDs. Within simulated condensates, networks inter-sticker crosslinks organize PLCDs into small-world topologies. The dimensions vary with spatial location, being most expanded at preferring be oriented perpendicular interface. results demonstrate even simple type macromolecule feature inhomogeneous organizations molecules interfacial features likely prime them for biochemical activity.

Язык: Английский

Процитировано

150

Secondary nucleation and elongation occur at different sites on Alzheimer’s amyloid-β aggregates DOI Creative Commons
Tom Scheidt, Urszula Łapińska, Janet R. Kumita

и другие.

Science Advances, Год журнала: 2019, Номер 5(4)

Опубликована: Апрель 5, 2019

Chaperone regulation of individual microscopic events in Aβ42 aggregation reveals the nature active sites on amyloid fibrils.

Язык: Английский

Процитировано

149